Alimentary Pharmacology & Therapeutics · 2011 · 12 citations · 19 references
MedicineClinical SciencesGastroenterologyGeriatric AssessmentGeriatricsEsophageal DiseasesFunctional Gastrointestinal DisordersGastroesophageal Reflux DiseaseGastroesophageal Reflux Disease CareGastroesophageal Reflux Disease PharmacotherapyGerd Symptom AssessmentHealthcare EffectivenessHealthcare Resource Use Data CollectionHealthcare Resource UtilizationMorbidity PredictionPharmacologic Therapy For GerdRefractory Gastroesophageal Reflux Disease
BACKGROUND: Approximately one-third of gastro-oesophageal reflux disease (GERD) patients demonstrate refractory symptoms following treatment with proton pump inhibitor (PPI) therapy. AIM: To develop a refractory GERD score that can be applied to predict patients' healthcare utilisation. METHODS: We enrolled adults (≥18 years) with a diagnosis of GERD. Refractory GERD was evaluated on an 8-point scale where 1 point was given for each of the following criteria: doubling, addition, or switching of GERD medication dose, receipt of a GERD-related endoscopic procedure or surgery, or ≥3 GERD-related outpatient visits. Refractory GERD was defined as the presence of two or more points. RESULTS: A total of 135,139 GERD patients (44% male) were analysed with a mean (±s.d.) age of 52.9 ± 15 years. The mean overall refractory GERD score was 1.12 ± 1.2 (range 0-8 on an 8-point scale); 31% of patients had refractory GERD with a mean score of 2.56 ± 0.82. Among patients with refractory GERD, 31% doubled their GERD medication, 28% added a new GERD medication, 60% switched GERD medications, 54% had a GERD-related procedure and 1% had a GERD-related surgery. Patients with refractory GERD were more likely to be female (59% vs. 55%, P < 0.001) and had a higher co-morbidity score (0.78 vs. 0.56, P < 0.001). The overall mean costs for refractory patients during the study period were significantly higher compared with treatment-responsive patients ($18,088 ± $36,220 vs. $11,044 ± $22,955, P < 0.001). CONCLUSIONS: Refractory GERD was present in approximately one-third of the GERD patients. We created a GERD refractory score that could define need for increased anti-reflux therapy and predict higher healthcare resource utilisation.
19
The burden of selected digestive diseases in the United States
Robert S. Sandler, James E. Everhart, Mark Donowitz et al. · Gastroenterology · 2002 · 1.5K citations · Full text